Right now, a package of two Evzio auto-injectors has a wholesale price of $3,750 — up from $575 in 2014 when the decades-old version of naloxone won regulatory approval. Advocates are urging the White House to use a law that would allow the government to use the patented invention without permission. In other news on the crisis: the downside of an addiction drug; DEA's crackdown nets arrests; Justice Department wants in on settlement negotiations with drugmakers; and more.
from Kaiser Health News https://ift.tt/2q45y0j
April 03, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Number Of Women Who Delivered Babies While Addicted To Opioids Quadrupled In 15-Year SpanThe study is the first to examine hospital data about opioid-addicted women delivering babies, and the numbers mirror well-known trends in opioid-exposed newborns. from Kaiser Health News https://ift.tt/2vUGw64 … Read More
Tumor Cells’ Tiny Defense Weapons Could Help Doctors Better Predict How Patients Will Respond To TherapiesThe weapons against the body's immune system could be used as biomarkers to figure out if the patient will respond to a very expensive type of therapy. In other public health news: psychologists at military prisons, cancer-ki… Read More
Trump Administration Endangered Public Health By Keeping Pesticide On Market, Appeals Court RulesThe court has ordered the EPA to ban chlorpyrifos, which can damage children's neurodevelopment. A coalition of farmworkers and environmental groups sued last year after then-EPA chief Scott Pruitt reversed an Obama-era effor… Read More
First Edition: August 10, 2018Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2OZUE6P … Read More
As Baby Boomers Age, Non-Emergency Medical Transportation Needs Are SkyrocketingNew companies are trying to fill the demand where taking an Uber or Lyft just won't cut it. Many patients opt to skip appointments when they can't find a ride, and those no-shows are costing billions in lost revenue. In other… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment